pittsburgh cancer institute started human testing treatment doctors enhance ability fight cancer maybe dissolve malignant tumors patients center first people receive treatment vitro sensitization which previously tested pittsburgh press reported sunday studies shown process fights remaining tumor cells newspaper cases animals cancer eliminated entirely researchers effect treatment patients their patients identity cancer disclosed tests began question point intermediate-term future therapeutic benefit kirkwood principal investigators study norman wolmark other investigator information gathered study should useful pointing there immediate effect patients tumors think treatment modified successful tumor response result vitro sensitization involves removing tumor irradiating inactivate tumor cells researchers press cells combined bacterium commonly vaccinate against tuberculosis order stimulate patient immune system patient injected irradiated cells produce sensitized lymphocytes cells critical natural defense against disease infection researchers other steps complex treatment involve tumor-fighting hormone interleukin-2 researchers press years before enough patients treated sufficient amount effectiveness treatment groundwork treatment begun years national cancer institute washington research scientist moved pittsburgh cancer institute which affiliated university pittsburgh where continued laboratory recently university michigan approach called adoptive cellular immunotheraphy widely approach cancer research tumors recognized weakly recognized immune system therefore continue growing because immune system little attack ronald herberman director pittsburgh cancer institute basically reason there great emphasis research enhance immune system newspaper herberman researchers ideally would almost immediate shrinkage tumor happen order expect treatment would actually large tumor
